Abstract
Pancreatic ductal adenocarcinoma (PDAC), the most prevalent type of pancreatic cancer, is an extremely aggressive and often lethal malignancy. The absence of effective therapeutic options motivates the search for molecular vulnerabilities in these tumors that may be explored for developing novel therapies for PDAC. In this study, we will search for essential genes to PDAC survival using a…